No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs556072344 |
chr13:50513229-50513230 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
2 |
rs562938209 |
chr13:50513233-50513234 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding regionlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs146643614 |
chr13:50513235-50513236 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs113648456 |
chr13:50513252-50513253 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs551890590 |
chr13:50513272-50513273 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding regionCpG islandlncRNA
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs560598746 |
chr13:50513340-50513341 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs386770915 |
chr13:50513398-50513399 |
Enhancers Flanking Active TSS Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs113425684 |
chr13:50513434-50513435 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs549416291 |
chr13:50513481-50513482 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs567513881 |
chr13:50513527-50513528 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs732729 |
chr13:50513535-50513536 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
12 |
rs544721131 |
chr13:50513557-50513558 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs547355018 |
chr13:50513572-50513573 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs189438620 |
chr13:50513602-50513603 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs544684069 |
chr13:50513603-50513604 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs558154675 |
chr13:50513612-50513613 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs35599370 |
chr13:50513677-50513678 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs397794999 |
chr13:50513683-50513684 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs147397289 |
chr13:50513684-50513685 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs140712319 |
chr13:50513685-50513686 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs181243525 |
chr13:50513737-50513738 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs538477565 |
chr13:50513738-50513739 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs553427943 |
chr13:50513831-50513832 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs565457452 |
chr13:50513849-50513850 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs535811438 |
chr13:50513875-50513876 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs541370770 |
chr13:50513935-50513936 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs563292365 |
chr13:50513946-50513947 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs561581830 |
chr13:50513969-50513970 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs576035427 |
chr13:50514048-50514049 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|